Journal of Immunology Research / 2011 / Article / Tab 1 / Review Article
HIV-Associated Tuberculosis Table 1 Newer Diagnostic Technologies for TB.
Technology Turnaround time Sensitivity gain References Ziehl Neelsen 2-3 days
[19 ] Solid Culture 30–60 days Baseline Liquid Culture 15–30 days +10% Rapid Speciation Compared to LJ Line Probe Assay 1st line Rif and INH (e.g., INNOLiPA Rif.TB and the GenoTyp MTBDR) 2–4 days Currently smear positive only [20 , 21 ] Integrated Nucleic Acid Amplification Tests (INH and Rif only) GeneXpert MTB/RIF 90 minutes +40% compared to ZN [22 ] The Microscopic-Observation Drug-Susceptibility (MODS) 7 Days +14% compared to LJ [23 ] T-cell-based Assays (Interferon-
-based assays) 16–24 hrs (if not batch run) Overall sensitivity gain unknown Sensitivity: 76% for QTF-G, and 90% for Elispot, unable to distinguish latent from and active TB, role in HIV infection uncertain [24 ] LED-based Flourescent Microscopy 1-2 days +10% Compared to ZN [19 ] TB Antigen Detection (Lipoarabinomannan –LAM Assay) 3-4 hours Point of care testing available soon Overall sensitivity gain unknown 52% sensitivity in HIV+ patients, specificity 89% [18 , 25 ]